AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2016
Dec 23, 2016
35134_dirs_2016-12-22_1a8243e4-d3ff-4ea6-be58-c2666e197b07.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2016-12-21
Reporting Person: Russell Angus C. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-12-21 | Non-Qualified Stock Option (right to buy) | $5.68 | A | 25000 | Acquired | 2026-12-20 | Common Stock (25000) | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16